91 related articles for article (PubMed ID: 6820669)
41. mRNA levels and enzyme activities of protein phosphatases in drug-resistant rat ascites hepatomas.
Saadat M; Saeki H; Kudo T; Mizuno Y; Kikuchi K
Oncol Res; 1995; 7(10-11):505-10. PubMed ID: 8866662
[TBL] [Abstract][Full Text] [Related]
42. Bioreduction of RSU 1069 and mitomycin C after dearterialization.
Wang LQ; Persson BG; Bengmark S
Eur J Surg Oncol; 1993 Oct; 19(5):455-62. PubMed ID: 8405482
[TBL] [Abstract][Full Text] [Related]
43. Mitomycins.
Verweij J
Cancer Chemother Biol Response Modif; 1996; 16():48-56. PubMed ID: 8639396
[No Abstract] [Full Text] [Related]
44. Mitomycin C (NSC-26980)--clinical brochure.
Carter SK
Cancer Chemother Rep 3; 1968 Dec; 1(1):99-114. PubMed ID: 4990065
[No Abstract] [Full Text] [Related]
45. Schedule dependency of anticancer effect of 1-beta-D-arabinofuranosylcytosine on rat ascites hepatomas.
Abe I; Sato S; Watanabe M; Sato H
Sci Rep Res Inst Tohoku Univ Med; 1978 Sep; 25(1-2):20-3. PubMed ID: 741221
[No Abstract] [Full Text] [Related]
46. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
[TBL] [Abstract][Full Text] [Related]
47. Structural determination of the conjugate of human serum albumin with a mitomycin C derivative, KW-2149, by matrix-assisted laser desorption/ionization mass spectrometry.
Yasuzawa T; Tomer KB
Bioconjug Chem; 1997; 8(3):391-9. PubMed ID: 9177846
[TBL] [Abstract][Full Text] [Related]
48. Sodium selenite modulates tumour marker indices in N-nitrosodiethylamine-initiated and phenobarbital-promoted rat liver carcinogenesis.
Thirunavukkarasu C; Sakthisekaran D
Cell Biochem Funct; 2003 Jun; 21(2):147-53. PubMed ID: 12736904
[TBL] [Abstract][Full Text] [Related]
49. [Action of hydrazine sulfate on energy metabolism and glycogen synthesis in animal liver and tumor cells].
Misheneva VS; Burova TM; Goriukhina TA
Vopr Onkol; 1980; 26(2):95-7. PubMed ID: 7361502
[No Abstract] [Full Text] [Related]
50. [Factors affecting the effect of anticancer drugs. 1. The effect of mitomycin C in vitro and in vivo].
Ishikawa Y; Fukushima M; Horimai T; Sato T; Machida S
Igaku To Seibutsugaku; 1967 Feb; 74(2):96-100. PubMed ID: 5624336
[No Abstract] [Full Text] [Related]
51. [EXPERIMENTAL STUDIES ON THE PREVENTION OF HEMATOGENIC METASTASIS OF CANCER WITH ANTICANCER DRUGS].
UENO K
Kumamoto Igakkai Zasshi; 1964 Feb; 38():81-99. PubMed ID: 14162556
[No Abstract] [Full Text] [Related]
52. Antitumor activity of 2,6-bis(halomethyl)piperidines on rat ascites hepatomas.
Miyamoto K; Sanae F; Koshiura R
Gan; 1978 Oct; 69(5):703-7. PubMed ID: 729968
[No Abstract] [Full Text] [Related]
53. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
[TBL] [Abstract][Full Text] [Related]
54. Mitomycin: its evolving role in the treatment of breast cancer.
Hortobagyi GN
Oncology; 1993 Apr; 50 Suppl 1():1-8. PubMed ID: 8483556
[TBL] [Abstract][Full Text] [Related]
55. Drug resistance of hypoxic tumour cells in vitro.
Ludwig C
Cancer Treat Rev; 1984 Mar; 11 Suppl A():173-8. PubMed ID: 6428739
[No Abstract] [Full Text] [Related]
56. [Anti-hepatoma effect of arsenic trioxide on rat liver cancers induced by 2-acetamidofluorene].
Huang JF; Tan B; Wei Q; Zhang H; Ni RZ
Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):623-5. PubMed ID: 16093000
[No Abstract] [Full Text] [Related]
57. Effect of mitomycin C on the protein and non-protein nitrogen content of mouse fibrosarcoma.
Chakravorty R; Roy DK
Indian J Exp Biol; 1972 Jan; 10(1):5-7. PubMed ID: 4638010
[No Abstract] [Full Text] [Related]
58. Mitomycin C.
Umsawasdi T
J Med Assoc Thai; 1976 Jan; 59(1):1-5. PubMed ID: 814182
[No Abstract] [Full Text] [Related]
59. Intracavitary administration: pharmacokinetic advantages of macromolecular anticancer agents against peritoneal and pleural carcinomatoses.
Kimura M; Konno T; Miyamoto Y; Kojima Y; Maeda H
Anticancer Res; 1998; 18(4A):2547-50. PubMed ID: 9703908
[TBL] [Abstract][Full Text] [Related]
60. Studies on the role of host resistance in the therapy of mouse ascites hepatoma MH 134.
Kudo T
Nihon Geka Hokan; 1967 Sep; 36(5):542-64. PubMed ID: 5625054
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
